We present here a case report of a 69-yearold female patient with T granular lymphocyte proliferative disorder (T-GLPD) expressing the g/d T-cell receptor. The patient had been treated for rheumatoid arthritis for 25 years, and presented with mild anaemia. Cell-surface marker analysis was carried out using flow cytometry and natural killer function was determined using a chromium release assay. The case report is followed by a summary of the 21 other g/d T-GLPD cases reported in the literature and a comparison of their clinical characteristics with those of T-GLPD cases expressing the a/b T-cell receptor. The clinical symptoms and the frequency of association with rheumatoid arthritis are similar in g/d and a/b T-GLPD, but a prevalence of the CD8-cell-surface marker and enhanced natural killer function appear to be characteristics of g/d T-GLPD.
Introduction
Large granular lymphocytes (LGLs) are large lymphocytes with cytoplasmic azurophilic granulation that comprise approximately 10 -15% of the white blood cells in the peripheral blood of healthy people. 1 
Most
LGLs are derived from natural killer (NK) cells, with a few being derived from T-lymphocytes. Disorders characterized by a chronic increase in LGLs are known as LGL leukaemia or granular lymphocyte proliferative disorder (GLPD). GLPD comprises two types -NK-cell-and T-cell-derived (T-GLPD), with the latter accounting for 85% of cases. 2 T-GLPD is a clonal disorder that frequently presents with neutropenia and may be associated with autoimmune disorders or pure red-cell aplasia. 3 Most T-GLPD cases express the α/β T-cell receptor (TCR); cases expressing the γ/δ TCR are rare. 4 We report here a patient with rheumatoid arthritis who developed γ/δ T-GLPD in association with anaemia, and review the cases of γ/δ LGL published to date.
Case report
The patient is a 69-year-old female with a 25-year history of rheumatoid arthritis (RA), classified as stage III and class III according to the Steinbrocker classification. The patient's haemoglobin level had been within normal limits until August 2000, but anaemia then developed and gradually worsened until the haemoglobin level was 90 g/l in April 2002. In November 2002 she suffered from bacterial pneumonia and was admitted to Kakogawa Prefectural Hospital, Hyogo, Japan. Laboratory findings on admission showed a leucocyte count of 7.9 × 10 9 /l, a haemoglobin level of 84 g/l, a red cell count of 2.68 × 10 12 /l, a mean corpuscular volume of 101 fl, a platelet count of 416 × 10 9 /l and a reticulocyte count of 1.7%. Differential leucocyte counts were 68% for lymphocytes, 25% for neutrophils, 6% for monocytes, 2% for eosinophils and 1% for basophils. Almost all of the lymphocytes were identified morphologically as LGLs (Fig. 1) . The serum erythropoietin level was 116 mU/ml (normal range 8 -36 mU/ml) and the rheumatic factor was 33 IU/ml (normal < 15 IU/ml), while the direct Coombs' test and antinuclear factor were negative. 584 M Zenibayashi, K Saigo, N Chayahara et al.
T-GLPD associated with RA Sternal bone marrow aspiration showed a total nucleated cell count of 187 × 10 9 /l, consisting of 6.5% erythroid progenitors, 74.5% myeloid cells and 12.9% LGLs. No cytogenetic abnormalities were detected. The results of cell-surface marker analysis using flow cytometry of peripheral blood lymphocytes are given in Table 1 .
Southern blot analysis of TCRs using a J γ probe demonstrated a monoclonal rearrangement. 5 NK function determined by a conventional chromium release assay was 60% (normal range 18 -40%). 6 After recovering from the episode of pneumonia, the patient continued to be well, even though complete blood count data remained essentially unchanged and the number of lymphocytes with LGL morphology in the peripheral blood was still around 65%. As the patient's clinical condition has remained quite stable, no additional treatment has been required.
Discussion
Human γ/δ T-lymphocytes account for 1 -10% of normal circulating peripheral blood T-cells, 2 -4% of the T-cells in normal lymph nodes, 3 -5% of medullary thymocytes and 15% of splenic T-cells. 7 Immunologically, γ/δ T-lymphocytes are thought to form a defence against invasive microorganisms and haematopoietic tumour cells.
Several tumours derived from γ/δ T-lymphocytes have been identified and hepatosplenic γ/δ T-cell lymphoma has been included as a disease entity in the T-GLPD associated with RA lymphoma (PTCL) patients, suggesting that γ/δ T-cell-derived tumours may not be as rare as was once thought. They also reported that PTCL cases expressing γ/δ TCRs had a worse prognosis than those expressing α/β TCRs. Cases of T-GLPD with tumour cells expressing γ/δ TCRs are rare; all reported cases, including the one presented here, are listed in Table 2 . Of these patients, 29% had RA, 65% had anaemia (haemoglobin M Zenibayashi, K Saigo, N Chayahara et al.
T-GLPD associated with RA T-GLPD associated with RA < 115 g/l) and 69% had neutropenia (< 1.5 × 10 9 /l), and the mean age at diagnosis was 51.7 years (range 21 -80 years). These values are essentially similar to those reported by Dhodapkar et al. 26 in 68 patients with T-LGL of unspecified type and by Semenzato et al. 27 in 195 patients with α/β T-LGL. With regard to the prognosis for γ/δ T-LGL, 76% (13 out of 17 in Table 2 ) of the published cases proved to be stable with either no treatment or only transient use of a single agent such as a steroid, cyclosporin or cyclophosphamide; treatment was not reported for the remaining five cases. The clinical courses are again indistinguishable from those reported by Dhodapkar et al. 26 Cell-surface marker examination in the 21 published cases of γ/δ T-GLPD cases showed that only 19% (four out of 21) had a CD3+ CD4-CD8+ phenotype, 33% (seven out of 21) had a CD3+ CD4-CD8w+ phenotype and 60% (nine out of 15 tested for CD16) had a CD3+ CD16+ phenotype. These values are in contrast to a CD8+ rate of 75% for α/β T-LGL cases reported by Semenzato et al. 27 Interestingly, NK activity was found to have increased in five out of six analysed subjects, including the present case ( Table 2) , indicating that leukaemic cells can also function as NK cells. In contrast, Loughran 1 reported that NK activity in T-LGL patients was diminished or absent. The results of some studies 28, 29 suggest that the lack of CD5 antigen may characterize γ/δ T-GLPD cases with increased NK function; this is supported by the fact that neoplastic NK cells always lack CD5. 30 In conclusion, the clinical features of g/d T-GLPD appear to be similar to those of α/β T-GLPD except for surface marker characteristics and enhanced NK function.
